These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 31972222)
1. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer. Madigan JP; Robey RW; Poprawski JE; Huang H; Clarke CJ; Gottesman MM; Cabot MC; Rosenberg DW Exp Cell Res; 2020 Mar; 388(2):111860. PubMed ID: 31972222 [TBL] [Abstract][Full Text] [Related]
2. Ceramide glycosylation potentiates cellular multidrug resistance. Liu YY; Han TY; Giuliano AE; Cabot MC FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390 [TBL] [Abstract][Full Text] [Related]
3. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Liu YY; Hill RA; Li YT Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer. Kartal Yandım M; Apohan E; Baran Y Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611 [TBL] [Abstract][Full Text] [Related]
5. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. Liu YY; Han TY; Giuliano AE; Cabot MC J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062 [TBL] [Abstract][Full Text] [Related]
6. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281 [TBL] [Abstract][Full Text] [Related]
7. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer. Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680 [TBL] [Abstract][Full Text] [Related]
8. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. Liu YY; Han TY; Giuliano AE; Ichikawa S; Hirabayashi Y; Cabot MC Exp Cell Res; 1999 Nov; 252(2):464-70. PubMed ID: 10527636 [TBL] [Abstract][Full Text] [Related]
9. Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy. Litvak DA; Bilchik AJ; Cabot MC J Gastrointest Surg; 2003 Jan; 7(1):140-148. PubMed ID: 12559195 [TBL] [Abstract][Full Text] [Related]
10. Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase. Gupta V; Patwardhan GA; Zhang QJ; Cabot MC; Jazwinski SM; Liu YY J Lipid Res; 2010 Apr; 51(4):866-74. PubMed ID: 19826105 [TBL] [Abstract][Full Text] [Related]
11. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity. Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111 [TBL] [Abstract][Full Text] [Related]
12. The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs. Veldman RJ; Mita A; Cuvillier O; Garcia V; Klappe K; Medin JA; Campbell JD; Carpentier S; Kok JW; Levade T FASEB J; 2003 Jun; 17(9):1144-6. PubMed ID: 12692077 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide. Honda T; Motoyoshi K; Kasahara J; Yamagata K; Takahashi H; Nakamura H; Murayama T Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158817. PubMed ID: 32980536 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation. Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008 [TBL] [Abstract][Full Text] [Related]
15. Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells. Liu YY; Patwardhan GA; Bhinge K; Gupta V; Gu X; Jazwinski SM Cancer Res; 2011 Mar; 71(6):2276-85. PubMed ID: 21278235 [TBL] [Abstract][Full Text] [Related]
16. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496 [TBL] [Abstract][Full Text] [Related]
17. KIF18b-dependent hypomethylation of PARPBP gene promoter enhances oxaliplatin resistance in colorectal cancer. Hong B; Lu R; Lou W; Bao Y; Qiao L; Hu Y; Liu K; Chen J; Bao D; Ye M; Fang Z; Gong C; Zhang X Exp Cell Res; 2021 Oct; 407(2):112827. PubMed ID: 34508743 [TBL] [Abstract][Full Text] [Related]
18. A role for ceramide in driving cancer cell resistance to doxorubicin. Liu YY; Yu JY; Yin D; Patwardhan GA; Gupta V; Hirabayashi Y; Holleran WM; Giuliano AE; Jazwinski SM; Gouaze-Andersson V; Consoli DP; Cabot MC FASEB J; 2008 Jul; 22(7):2541-51. PubMed ID: 18245173 [TBL] [Abstract][Full Text] [Related]
19. Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo. Khiste SK; Hosain SB; Dong Y; Uddin MB; Roy KR; Hill RA; Liu Z; Liu YY Sci Rep; 2017 Jun; 7(1):2976. PubMed ID: 28592871 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor. Guan S; Liu YY; Yan T; Zhou J Biochem Biophys Res Commun; 2016 Aug; 476(4):230-236. PubMed ID: 27221045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]